Food sits in the stomach for too long, which can lead to a host of debilitating problems
Over 40 research programs having been discontinued since the IRA was enacted
Resmetirom, which was approved by the Food and Drug Administration (FDA) in March 2024, acts hepatocentrically to accelerate -oxidation, lower atherogenic lipoproteins, and deliver early signals necessary for fibrosis regression, all while largely avoiding systemic thyrotoxic effects
All factual claims are supported by cited sources where available
Double benefit: the L-Carnitine enhances the fat-elimination effect of ultrasonic cavitation while the ultrasound amplifies the delivery depth of the L-Carnitine itself
[68] Chen JK, Chen TT, Nguyen M, Huang L, Chang J, Friesen R, et al